Literature DB >> 19726782

Additional patient outcomes and pathways in evaluations of testing.

Patrick M M Bossuyt1, Kirsten McCaffery.   

Abstract

Before medical tests are introduced into practice, they should be properly evaluated. Randomized trials and other comprehensive evaluations of tests and test strategies can best be designed based on an understanding of how tests can benefit or harm patients. Tests primarily affect patients' health by guiding clinical decision making and downstream management, such as the decision to order more tests or to start, stop, or modify treatment. In this article, the authors demonstrate that tests can have additional effects on patient outcome, which may be cognitive, emotional, social, or behavioral. They present a framework to help researchers and policy makers consider the cognitive, emotional, social, and behavioral effects of testing. These additional effects may be important themselves and may also influence the clinical outcomes of testing through different pathways. The authors provide examples from test evaluations in the literature to illustrate how these additional effects can be important in the evaluation of testing or indeed any health intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19726782     DOI: 10.1177/0272989X09347013

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  19 in total

1.  Evidence-based laboratory medicine: is it working in practice?

Authors:  Christopher P Price
Journal:  Clin Biochem Rev       Date:  2012-02

2.  Patient-Centered Outcomes Related to Imaging Testing in US Primary Care.

Authors:  Monica L Zigman Suchsland; Elizabeth Witwer; Anjali R Truitt; Danielle C Lavallee; Ying Zhang; Philip Posner; Brian Do; Patrick M Bossuyt; Victoria Hardy; Matthew J Thompson
Journal:  J Am Coll Radiol       Date:  2018-10-25       Impact factor: 5.532

3.  Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.

Authors:  Kirsten J McCaffery; Les Irwig; Robin Turner; Siew Foong Chan; Petra Macaskill; Mary Lewicka; Judith Clarke; Edith Weisberg; Alex Barratt
Journal:  BMJ       Date:  2010-02-23

Review 4.  Additional effects of the cervical length measurement in women with preterm contractions: a systematic review.

Authors:  Jolande Y Vis; Rosanna A Kuin; William A Grobman; Ben Willem J Mol; Patrick M M Bossuyt; Brent C Opmeer
Journal:  Arch Gynecol Obstet       Date:  2011-04-12       Impact factor: 2.344

5.  Chapter 3: choosing the important outcomes for a systematic review of a medical test.

Authors:  Jodi B Segal
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

6.  Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.

Authors:  Thomas A Trikalinos; Shalini Kulasingam; William F Lawrence
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

Review 7.  Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine.

Authors:  Ildar Akhmetov; Rostyslav V Bubnov
Journal:  EPMA J       Date:  2015-09-30       Impact factor: 6.543

8.  From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study.

Authors:  Hendrik Koffijberg; Bas van Zaane; Karel G M Moons
Journal:  BMC Med Res Methodol       Date:  2013-01-31       Impact factor: 4.615

9.  The influence of medical testing on patients' health: an overview from the gynecologists' perspective.

Authors:  Jolande Y Vis; Myra C B van Zwieten; Patrick M M Bossuyt; Karel G M Moons; Marcel G W Dijkgraaf; Kirsten J McCaffery; Ben Willem J Mol; Brent C Opmeer
Journal:  BMC Med Inform Decis Mak       Date:  2013-10-10       Impact factor: 2.796

10.  Women's perspectives of the fetal fibronectin testing process: a qualitative descriptive study.

Authors:  Wendy E Peterson; Ann E Sprague; Jessica Reszel; Mark Walker; Deshayne B Fell; Sherry L Perkins; Sandra I Dunn; Moya Johnson
Journal:  BMC Pregnancy Childbirth       Date:  2014-06-04       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.